BLOOMFIELD — The state has awarded $12 million in grant funding to 48 cannabis businesses to enable entrepreneurs, particularly those from communities historically harmed by the War on Drugs, to start and expand their cannabis businesses in New Jersey.
This funding initiative is designed to eliminate long-standing barriers to entry and provides the startups with a $250,000 grant, the largest cannabis social equity grant of its kind in the nation.
The first phase of the Cannabis Equity Grant Program, known as the Joint Ventures Grant, launched earlier this year with a primary objective of assisting recreational cannabis startups with the capital to manage financial burdens and challenges when transitioning from a conditional license to an annual license, according to a press release from the New Jersey Economic Development Authority.
The Essex County awardees included Nightjar Holdings of Bloomfield; Elevated by the Cannabosslady of Maplewood; La Vida Gardens of Belleville; Treehouse Ventures of West Orange and Yerrr Canna of West Orange.
To ensure the communities harmed by racially-biased marijuana arrests also reap these financial benefits, 40% of the Joint Ventures Grant funding was allocated for qualifying social equity applicants, and an additional five percent was designated for businesses located in Impact Zones.
“As the cannabis industry continues to reach new heights in New Jersey, it is important that we build on our efforts to support the businesses seeking to enter and grow within this emerging market. The Cannabis Equity Grant Program allows us to simultaneously expand the pool of cannabis businesses in our state while also focusing on those communities most impacted by the unethical War on Drugs,” said Gov. Phil Murphy. “As we work to create a stronger, fairer, and more equitable cannabis market, our Administration will continue to increase access and opportunity to the small businesses entering the industry.”
NJEDA Chief Executive Officer Tim Sullivan said that Cannabis Equity Grant Program will foster greater participation in the growing cannabis industry, especially for communities harmed by the War on Drugs.
“Greater investment in the cannabis industry ensures more entrepreneurs, residents, and communities benefit, reversing historical injustices,” Sullivan said.
Dianna Houenou, chair of the New Jersey Cannabis Regulatory Commission, said the grant program has helped to set up the New Jersey cannabis market as an example for the rest of the country.
“We were grateful NJEDA stepped up to partner with us and we were able to offer our insight into the cannabis industry and to present our vision for an equitable New Jersey market – with particular concern for those who lack access to personal or familial capital, or to traditional sources of business funding,” Houenou said. “We look forward to even more targeted investment into social equity businesses and those owned by local minority-, women- and disabled veteran-owned businesses.”
This announcement precedes Phase II’s Seed Equity Grant, which will also benefit from the additional funding when it launches later this year. Phase II will exclusively ensure the communities most adversely impacted by the War on Drugs have equitable access to the cannabis industry, the release said.
To this end, 100% of the Phase II Seed Equity Grant funding is reserved for qualifying social equity applicants. Phase II awardees will receive $150,000 in grant funds along with technical assistance to ensure that their businesses accrue the resources and support necessary to succeed.
The technical assistance component will provide licensure process training, assistance in building a cannabis business team, financial management, guidance on securing investors, and development of supply chain management to name a few.
To learn additional information about the program and to view the 48 Joint Ventures Grant recipients, feel free to visit the website at www.njeda.gov/cannabis-equity-grant-program/
About the Author
